Advertisement
Canada markets closed

  • S&P/TSX

    21,969.24
    +83.86 (+0.38%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • DOW

    38,239.66
    +153.86 (+0.40%)
     

  • CAD/USD

    0.7316
    -0.0007 (-0.10%)
     

  • CRUDE OIL

    83.64
    +0.07 (+0.08%)
     

  • Bitcoin CAD

    87,344.97
    -1,292.45 (-1.46%)
     

  • CMC Crypto 200

    1,332.13
    -64.41 (-4.61%)
     

  • GOLD FUTURES

    2,348.70
    +6.20 (+0.26%)
     

  • RUSSELL 2000

    2,002.00
    +20.88 (+1.05%)
     

  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     

  • NASDAQ

    15,927.90
    +316.14 (+2.03%)
     

  • VOLATILITY

    15.03
    -0.34 (-2.21%)
     

  • FTSE

    8,139.83
    +60.97 (+0.75%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6839
    +0.0018 (+0.26%)
     
MARKETS LIVE BLOG:

STOCKS RISE, LED BY STELLAR ALPHABET, MICROSOFT RESULTS

Chevron, Exxon under pressure as falling natural gas prices hit earnings

Stocks in play: Levitee Labs Inc.

Baystreet.ca

Recently announced the appointment of Noha ElSayed, B.Sc.Pharm, APA, as Executive Director, Levitee Clinics and Levitee Pharmacies, Alberta Region. Mrs. ElSayed brings a wealth of expertise gained through a variety of clinical and managerial positions held in retail pharmacies, hospitals, and primary care settings while working as a pharmacist for the last 20 years, including 11 years as a pharmacy manager. Levitee Labs Inc. shares C.LVT are trading unchanged at $0.38.

Read: